Cover Image

A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway

CD4+CD25+ regulatory T cells (Tregs) represent a specialized subpopulation of T cells, which are essential for maintaining peripheral tolerance and preventing autoimmunity. The immunomodulatory effects of Tregs depend on their activation status. Here we show that, in contrast to conventional anti-CD...

Full description

Saved in:
Bibliographic Details
Main Authors: Helling, Bianca (Author) , Haas, Jürgen (Author) , Wildemann, Brigitte (Author) , Fritz, Brigitte (Author)
Format: Article (Journal)
Language:English
Published: 2015
In: Immunology & cell biology
Year: 2015, Volume: 93, Issue: 4, Pages: 396-405
ISSN:1440-1711
DOI:10.1038/icb.2014.102
Online Access:Verlag, Volltext: http://dx.doi.org/10.1038/icb.2014.102
Verlag, Volltext: http://www.nature.com/icb/journal/v93/n4/full/icb2014102a.html?foxtrotcallback=true
Get full text
Author Notes:Bianca Helling, Martin König, Benjamin Dälken, Andre Engling, Wolfgang Krömer, Katharina Heim, Holger Wallmeier, Jürgen Haas, Brigitte Wildemann, Brigitte Fritz, Helmut Jonuleit, Jan Kubach, Theodor Dingermann, Heinfried H. Radeke, Frank Osterroth, Christoph Uherek, Niklas Czeloth and Jörg Schüttrumpf

MARC

LEADER 00000caa a2200000 c 4500
001 1561069086
003 DE-627
005 20230428162114.0
007 cr uuu---uuuuu
008 170720s2015 xx |||||o 00| ||eng c
024 7 |a 10.1038/icb.2014.102  |2 doi 
035 |a (DE-627)1561069086 
035 |a (DE-576)491069081 
035 |a (DE-599)BSZ491069081 
035 |a (OCoLC)1340977335 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Helling, Bianca  |d 1984-  |e VerfasserIn  |0 (DE-588)1069304492  |0 (DE-627)821643703  |0 (DE-576)428575544  |4 aut 
245 1 2 |a A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway  |c Bianca Helling, Martin König, Benjamin Dälken, Andre Engling, Wolfgang Krömer, Katharina Heim, Holger Wallmeier, Jürgen Haas, Brigitte Wildemann, Brigitte Fritz, Helmut Jonuleit, Jan Kubach, Theodor Dingermann, Heinfried H. Radeke, Frank Osterroth, Christoph Uherek, Niklas Czeloth and Jörg Schüttrumpf 
264 1 |c 2015 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a published online 16 December 2014 
500 |a Gesehen am 20.07.2017 
520 |a CD4+CD25+ regulatory T cells (Tregs) represent a specialized subpopulation of T cells, which are essential for maintaining peripheral tolerance and preventing autoimmunity. The immunomodulatory effects of Tregs depend on their activation status. Here we show that, in contrast to conventional anti-CD4 monoclonal antibodies (mAbs), the humanized CD4-specific monoclonal antibody tregalizumab (BT-061) is able to selectively activate the suppressive properties of Tregs in vitro. BT-061 activates Tregs by binding to CD4 and activation of signaling downstream pathways. The specific functionality of BT-061 may be explained by the recognition of a unique, conformational epitope on domain 2 of the CD4 molecule that is not recognized by other anti-CD4 mAbs. We found that, due to this special epitope binding, BT-061 induces a unique phosphorylation of T-cell receptor complex-associated signaling molecules. This is sufficient to activate the function of Tregs without activating effector T cells. Furthermore, BT-061 does not induce the release of pro-inflammatory cytokines. These results demonstrate that BT-061 stimulation via the CD4 receptor is able to induce T-cell receptor-independent activation of Tregs. Selective activation of Tregs via CD4 is a promising approach for the treatment of autoimmune diseases where insufficient Treg activity has been described. Clinical investigation of this new approach is currently ongoing. 
700 1 |a Haas, Jürgen  |e VerfasserIn  |0 (DE-588)1073216810  |0 (DE-627)828662290  |0 (DE-576)434731749  |4 aut 
700 1 |a Wildemann, Brigitte  |e VerfasserIn  |0 (DE-588)110203844  |0 (DE-627)510150004  |0 (DE-576)171831330  |4 aut 
700 1 |a Fritz, Brigitte  |e VerfasserIn  |0 (DE-588)1137033940  |0 (DE-627)893983136  |0 (DE-576)491068131  |4 aut 
773 0 8 |i Enthalten in  |t Immunology & cell biology  |d Hoboken, NJ : Wiley, 1987  |g 93(2015), 4, Seite 396-405  |h Online-Ressource  |w (DE-627)320496791  |w (DE-600)2011707-3  |w (DE-576)091143101  |x 1440-1711  |7 nnas  |a A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway 
773 1 8 |g volume:93  |g year:2015  |g number:4  |g pages:396-405  |g extent:10  |a A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway 
856 4 0 |u http://dx.doi.org/10.1038/icb.2014.102  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.nature.com/icb/journal/v93/n4/full/icb2014102a.html?foxtrotcallback=true  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20170720 
993 |a Article 
994 |a 2015 
998 |g 1137033940  |a Fritz, Brigitte  |m 1137033940:Fritz, Brigitte  |d 910000  |d 911100  |e 910000PF1137033940  |e 911100PF1137033940  |k 0/910000/  |k 1/910000/911100/  |p 10 
998 |g 110203844  |a Wildemann, Brigitte  |m 110203844:Wildemann, Brigitte  |d 910000  |d 911100  |e 910000PW110203844  |e 911100PW110203844  |k 0/910000/  |k 1/910000/911100/  |p 9 
998 |g 1073216810  |a Haas, Jürgen  |m 1073216810:Haas, Jürgen  |d 910000  |d 911100  |e 910000PH1073216810  |e 911100PH1073216810  |k 0/910000/  |k 1/910000/911100/  |p 8 
999 |a KXP-PPN1561069086  |e 2974613705 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"recId":"320496791","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2011707-3"],"issn":["1440-1711"],"eki":["320496791"],"doi":["10.1111/(ISSN)1440-1711"]},"disp":"A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathwayImmunology & cell biology","origin":[{"publisher":"Wiley ; Nature Publ. Group ; Springer Nature","dateIssuedKey":"1987","dateIssuedDisp":"1987-","publisherPlace":"Hoboken, NJ ; Melbourne ; Heidelberg"}],"titleAlt":[{"title":"Immunology and cell biology"}],"note":["Gesehen am 29.10.2018"],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"issue":"4","year":"2015","pages":"396-405","text":"93(2015), 4, Seite 396-405","volume":"93","extent":"10"},"language":["eng"],"pubHistory":["65.1987 -"],"title":[{"title_sort":"Immunology & cell biology","title":"Immunology & cell biology","subtitle":"official publication of the Australasian Society for Immunology"}]}],"note":["published online 16 December 2014","Gesehen am 20.07.2017"],"name":{"displayForm":["Bianca Helling, Martin König, Benjamin Dälken, Andre Engling, Wolfgang Krömer, Katharina Heim, Holger Wallmeier, Jürgen Haas, Brigitte Wildemann, Brigitte Fritz, Helmut Jonuleit, Jan Kubach, Theodor Dingermann, Heinfried H. Radeke, Frank Osterroth, Christoph Uherek, Niklas Czeloth and Jörg Schüttrumpf"]},"title":[{"title_sort":"specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway","title":"A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1561069086","origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}],"person":[{"display":"Helling, Bianca","role":"aut","family":"Helling","given":"Bianca"},{"given":"Jürgen","family":"Haas","role":"aut","display":"Haas, Jürgen"},{"display":"Wildemann, Brigitte","role":"aut","family":"Wildemann","given":"Brigitte"},{"family":"Fritz","given":"Brigitte","display":"Fritz, Brigitte","role":"aut"}],"id":{"doi":["10.1038/icb.2014.102"],"eki":["1561069086"]},"physDesc":[{"extent":"10 S."}]} 
SRT |a HELLINGBIASPECIFICCD2015 

Similar Items